TY - JOUR
T1 - Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum
AU - Lamport, Anna Claire
AU - Chedrawe, Matthew
AU - Nichols, Matthew
AU - Robertson, George S.
N1 - Funding Information:
This work was supported by funding from the MS Society of Canada ( EGID 2983 ).
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/9/15
Y1 - 2019/9/15
N2 - Experimental autoimmune encephalomyelitis (EAE) and lysophosphatidylcholine (LPC)-induced demyelination were combined to study remyelination in a pro-inflammatory context. Two groups of female C57BL/6 mice were subjected either to EAE (EAE mice) or injected with just complete Freund's adjuvant (CFA) and pertussis toxin (PTX) followed by bilateral LPC and phosphate buffered saline injections in the corpus callosum on day 7 (CFA controls). Relative to CFA controls, EAE accelerated remyelination and increased innate immune cell activation, lymphocyte infiltration and cytokine gene expression in the LPC lesions. However, compared to CFA mice, remyelination was reduced (day 14) suggesting this aggressive immune response also compromised myelin repair in EAE mice.
AB - Experimental autoimmune encephalomyelitis (EAE) and lysophosphatidylcholine (LPC)-induced demyelination were combined to study remyelination in a pro-inflammatory context. Two groups of female C57BL/6 mice were subjected either to EAE (EAE mice) or injected with just complete Freund's adjuvant (CFA) and pertussis toxin (PTX) followed by bilateral LPC and phosphate buffered saline injections in the corpus callosum on day 7 (CFA controls). Relative to CFA controls, EAE accelerated remyelination and increased innate immune cell activation, lymphocyte infiltration and cytokine gene expression in the LPC lesions. However, compared to CFA mice, remyelination was reduced (day 14) suggesting this aggressive immune response also compromised myelin repair in EAE mice.
UR - http://www.scopus.com/inward/record.url?scp=85067417928&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067417928&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2019.576995
DO - 10.1016/j.jneuroim.2019.576995
M3 - Article
C2 - 31228686
AN - SCOPUS:85067417928
SN - 0165-5728
VL - 334
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
M1 - 576995
ER -